article thumbnail

Interview with Diana Nole, Microsoft Health & Life Sciences

Health Business Group

Nole , as she shares her progression from first-generation college graduate to Corporate Vice President of Microsoft Health & Life Sciences and General Manager of the Nuance Healthcare Division. Join me for a great discussion with Diana L. Contact us to learn more.

article thumbnail

How Open-Source Technologies Will Transform Digital Clinical Trials

HIT Consultant

Brian Williams, Life Sciences Strategy & Innovation at EPAM Systems, Inc. Although the traditional nearly decade-long clinical trial timelines completely collapsed during COVID, this truncating was not necessarily novel.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ArteraAI’s Prostate Test Earns Recognition in NCCN Guidelines for Prostate Cancer

HIT Consultant

What You Should Know: ArteraAI , a leader in artificial intelligence (AI)-powered cancer tests, today announced a significant achievement – the inclusion of their ArteraAI Prostate Test in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Prostate Cancer.

article thumbnail

Generative AI to bring 'transformative change,' says Froedtert/Inception Health CTO

Healthcare It News

By integrating genAI into the fabric of healthcare, we stand really on the brink of a new frontier in medicine and life sciences. The role of healthcare providers in AI extends far beyond clinical practice to encapsulate leadership, privacy, security and ethical governance.

article thumbnail

Syntropy, Evidium explain their data-centric healthcare tieup

Health Business Group

Syntropy’s product development team leader, Michael Vande-Vrede answered my questions about what it all means in practice. What are the key data quality challenges in clinical research and clinical practice?

article thumbnail

23andMe Scores FDA Clearance for Novel Cancer Immunotherapy Targeting NK Cells

HIT Consultant

The upcoming clinical trial will provide crucial data on the safety and efficacy of ‘1473, paving the way for its potential future use in clinical practice.

article thumbnail

Why Digital Pathology’s Ecosystem Won’t Support AI Startups

HIT Consultant

Here, large data sets for training exist, regulatory pathways are streamlined and some reimbursement already exists for the use of AI tools in clinical practice. And whilst clinical adoption of DP may be lagging behind, many vendors are choosing to renew focus on research-based applications to sustain themselves.